TY - JOUR T1 - Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with <sup>18</sup>F-fluorodeoxyglucose–positron emission tomography in stage IB cervical cancer JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 1351 LP - 1354 DO - 10.1136/ijgc-2019-000528 VL - 29 IS - 9 AU - Alexander J Lin AU - Jason D Wright AU - Farrokh Dehdashti AU - Barry A Siegel AU - Stephanie Markovina AU - Julie Schwarz AU - Premal H Thaker AU - David G Mutch AU - Matthew A Powell AU - Perry W Grigsby Y1 - 2019/11/01 UR - http://ijgc.bmj.com/content/29/9/1351.abstract N2 - Objective 18F-fluorodeoxyglucose–positron emission tomography (FDG-PET) detection of metastatic nodal disease is useful for guiding cervical cancer treatment but the impact of tumor histology is unknown. This study reports the detection of FDG avid pelvic and para-aortic lymph nodes in patients with early stage cervical cancer with squamous carcinoma and adenocarcinoma tumor histology.Methods Patients with International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IB1-2 cervical cancer who underwent pre-surgical FDG-PET between March 1999 and February 2018 were identified in a tertiary academic center database. All patients had radical hysterectomy with pelvic and para-aortic lymph node dissection. Detection of pelvic and para-aortic lymph nodes by FDG-PET versus surgical dissection was compared. FDG-PET sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were determined and stratified by tumor histology.Results We identified 212 patients with early stage cervical cancer (84% FIGO IB1, 16% IB2) who underwent pre-surgical FDG-PET; 137 (65%) patients had squamous carcinoma and 75 (35%) patients had adenocarcinoma. PET/computed tomography was performed in 189 (89%) patients and 23 (11%) had PET only. Surgical dissection revealed positive pelvic and para-aortic lymph nodes in 25% and 3.3% of patients, respectively. For squamous carcinoma, sensitivity, specificity, PPV, and NPV of FDG-PET for pelvic nodal metastasis were 44%, 99%, 95%, and 78%, respectively. For adenocarcinoma, the corresponding results for pelvic nodal metastasis were 25%, 99%, 67%, and 92%, respectively. The overall values for sensitivity, specificity, PPV, and NPV of FDG-PET for para-aortic nodal metastasis were 29%, 99%, 67%, and 98%, respectively.Discussion Pelvic nodal metastasis was less likely to be detected by FDG-PET in patients with early stage adenocarcinoma than with squamous carcinoma. ER -